Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nikkei BP is a leading Japanese media and publishing company that serves as a primary information hub for the life sciences, healthcare, and biotechnology sectors. As a subsidiary of Nikkei Inc., it operates flagship platforms such as Nikkei Biotech, which was Japan's first news service dedicated to the biotechnology industry. The company provides a comprehensive suite of services including professional journals, digital news platforms, market research, and consulting tailored to the pharmaceutical and medical device industries. Beyond publishing, Nikkei BP organizes major industry conferences and exhibitions that facilitate networking and business development within the Japanese healthcare ecosystem. Its publications, such as Nikkei Medical and Nikkei Healthcare, are considered essential resources for healthcare professionals, researchers, and policy makers in the region. By delivering deep analytical content and market intelligence, Nikkei BP plays a critical role in supporting the growth and innovation of the Japanese life sciences sector.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nikkei BP.